157 related articles for article (PubMed ID: 11549818)
1. Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases.
Ernst PB; Takaishi H; Crowe SE
Dig Dis; 2001; 19(2):104-11. PubMed ID: 11549818
[TBL] [Abstract][Full Text] [Related]
2. T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection.
Ernst PB; Pappo J
Acta Odontol Scand; 2001 Aug; 59(4):216-21. PubMed ID: 11570524
[TBL] [Abstract][Full Text] [Related]
3. The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system.
Nagura H; Ohtani H; Sasano H; Matsumoto T
Digestion; 2001; 63 Suppl 1():12-21. PubMed ID: 11173904
[TBL] [Abstract][Full Text] [Related]
4. The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease.
Ibraghimov A; Pappo J
Microbes Infect; 2000 Jul; 2(9):1073-7. PubMed ID: 10967287
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, immunity and vaccines for Helicobacter pylori.
Del Giudice G; Michetti P
Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
[TBL] [Abstract][Full Text] [Related]
6. Bacteria and mucosal inflammation of the gut: lessons from Helicobacter pylori.
Kuipers EJ; Michetti P
Helicobacter; 2005; 10 Suppl 1():66-70. PubMed ID: 16178973
[TBL] [Abstract][Full Text] [Related]
7. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and helicobacter-induced gastritis.
Bleich A; Mahler M
Pathobiology; 2005; 72(6):293-307. PubMed ID: 16582581
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Helicobacter pylori infection.
Hatakeyama M; Brzozowski T
Helicobacter; 2006 Oct; 11 Suppl 1():14-20. PubMed ID: 16925606
[TBL] [Abstract][Full Text] [Related]
9. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.
Wu MS; Chen CJ; Lin JT
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1878-82. PubMed ID: 16103430
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and gastroduodenal disease: pathogenesis and host-parasite interaction.
Solnick JV; Tompkins LS
Infect Agents Dis; 1992 Dec; 1(6):294-309. PubMed ID: 1344668
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes.
Portal-Celhay C; Perez-Perez GI
Clin Sci (Lond); 2006 Mar; 110(3):305-14. PubMed ID: 16464172
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Helicobacter pylori infection.
Peek RM
Springer Semin Immunopathol; 2005 Sep; 27(2):197-215. PubMed ID: 15928915
[TBL] [Abstract][Full Text] [Related]
13. Events at the host-microbial interface of the gastrointestinal tract IV. The pathogenesis of Helicobacter pylori persistence.
Peek RM
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G8-12. PubMed ID: 15961885
[TBL] [Abstract][Full Text] [Related]
14. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer.
Ernst PB; Gold BD
Annu Rev Microbiol; 2000; 54():615-40. PubMed ID: 11018139
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology and pathogenesis of Helicobacter pylori infection].
Hackelsberger A; Malfertheiner P
Praxis (Bern 1994); 1996 Nov; 85(45):1439-43. PubMed ID: 8975353
[TBL] [Abstract][Full Text] [Related]
16. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.
McGuckin MA; Every AL; Skene CD; Linden SK; Chionh YT; Swierczak A; McAuley J; Harbour S; Kaparakis M; Ferrero R; Sutton P
Gastroenterology; 2007 Oct; 133(4):1210-8. PubMed ID: 17919495
[TBL] [Abstract][Full Text] [Related]
17. Cytokines and the gut.
McAlindon ME; Mahida YR
Eur J Gastroenterol Hepatol; 1997 Nov; 9(11):1045-50. PubMed ID: 9431892
[TBL] [Abstract][Full Text] [Related]
18. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes.
Hunt RH
Scand J Gastroenterol Suppl; 1996; 220():3-9. PubMed ID: 8898429
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of Helicobacter pylori virulence factors in Iranian patients with gastrointestinal diseases.
Bagheri N; Azadegan-Dehkordi F; Rafieian-Kopaei M; Rahimian G; Asadi-Samani M; Shirzad H
Microb Pathog; 2016 Nov; 100():154-162. PubMed ID: 27666510
[TBL] [Abstract][Full Text] [Related]
20. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
